Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
Brain Trust Accelerator Fund
BurlingameSeed–Series A
1 person
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Growth
1 person
Virtus Inspire Ventures
Seed–Series A
7 people
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
UCB Ventures
BrusselsSeed–Series A
5 people
Allegory Capital
GlandSeed–Growth
1 person
Fjord Ventures
Laguna HillsSeed–Series A
1 person
Nesta Ventures
LondonSeed–Series A
1 person
New Age Ventures
New YorkPre-Seed–Series B
1 person
TriWise Capital
ShenzhenPre-Seed–Series B
1 person
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
MedVenture Partners, Inc.
TokyoPre-Seed–Growth
7 people
Cresswell Advisors
TorontoSeed–Series A
1 person
ENEA Tech e Biomedical
RomaPre-Seed–Series A
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Elron Ventures
Tel AvivSeed–Series A
4 people
WERU Investment Co. Ltd.
TokyoSeed–Series A
A. M. Pappas & Associates
DurhamPre-Seed–Series A
1 person
Airstream Venture Partners
WashingtonPre-Seed–Series A
1 person
Azafran Capital Partners
New YorkSeed–Series A
1 person
Azafran Capital Partners
New YorkSeed–Series A
1 person
Bio Sight Capital, Inc.
IbarakiSeed–Series A
1 person
MENTOR Capital Partners, Ltd.
YardleySeed–Growth
1 person
Nissay Capital
TokyoPre-Seed–Growth
1 person
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.

















